Purpose. The decline in methicillin-resistant Staphylococcus aureus (MRSA) isolation rates has become a general observation worldwide, including Japan. We hypothesized that some genetic shift in MRSA might cause this phenomenon, and therefore we investigated the genetic profiles among MRSA clinical isolates obtained from three different epidemic phases in Japan.
INTRODUCTION
Methicillin-resistant Staphylococcus aureus (MRSA) has long been one of the most important pathogens in both health care and community settings. Because of its higher rate of multi-drug resistance and production of intrinsic virulence factors, combined with high adaptability to human hosts and the clinical environment, MRSA can colonize and/or spread readily in both hospitals and communities, causing a variety of infections ranging from mild to severely life-threatening. The steady spread of MRSA since the 1980s has generally been accompanied by health care-associated transmission and infections in Europe and the USA, and during the 1990s and early 2000s there was a progressive year-on-year increase in the rate of healthcareassociated MRSA (HA-MRSA), which accounted for approximately 60 % of S. aureus isolates in US hospital ICUs in 2003 [1] . European Antimicrobial Resistance Surveillance System EARSS data from the early 2000s have shown that MRSA accounted for >25 % of invasive S. aureus in many European countries, and particularly high levels (>40 %) were noted in the UK, Greece, Italy, Malta and Ireland [2] . A similar situation was observed in the Asia-Pacific Region, where MRSA isolation rates were over 50 % in Japan, China, Taiwan and Singapore [3] . Besides HA-MRSA, the emergence of, rapid increase in and outbreaks of community-associated MRSA (CA-MRSA) have been reported worldwide since the 1990s [4] . The CA-MRSA is both phenotypically and genotypically unique in that it usually belongs to a genetic group possessing staphylococcal cassette chromosome mec (SCCmec) types IV or V, and frequently produces Panton-Valentine leukocidin (PVL), a S. aureus-specific exotoxin. Thus, CA-MRSA is considered to be more virulent than HA-MRSA and tends to have replaced conventional HA-MRSA in health care settings [5] . However, recent reports have indicated the downward trend of invasive MRSA rates in the USA, Europe and Asia since the early-to-mid 2000s [2, 6, 7] .
In Japan, MRSA has been a problem increasingly recognized since the 1980s, and the isolation frequency of MRSA from S. aureus increased rapidly from 5.6 % in 1985 to 50.0 % in 1988, followed by 58.6 % in 1990 [8, 9] . According to data from the Japan Nosocomial Infections Surveillance (JANIS) system of the Ministry of Health, Labour and Welfare, those rates have been maintained relatively constant between 2000 and 2007, while a decreasing trend has been observed since 2008 -60.3 % in 2008 to 48.2 % in 2015 -though the rates of methicillin-sensitive S. aureus (MSSA) have remained constant [10] (Fig. 1) .
In this study, MRSA isolates obtained from three different epidemic phases were analysed by characterizing the genetic profiles of MRSA populations during three separate phases, in order to endorse our hypothesis that the temporal genetic shift in clinical MRSAs may underlie the recent fall in the rates of MRSA isolation.
METHODS

Clinical isolates
A total of 353 non-duplicated MRSA isolates recovered from three different phases: pre-epidemic, epidemic and post-epidemic phases, in Japan were subjected to analysis, although no precise clinical background of each isolate, nor the epidemiological rule in selection of these isolates among many clinical isolates, was available. In 1990, coinciding with the pre-epidemic phase, 10 non-duplicated isolates each were collected from 43 national university hospitals [9] . Of those, two isolates per hospital were arbitrarily selected from which two isolates confirmed by us as having been misidentified using MALDI-TOF MS were omitted, making a total of 84 isolates from 43 hospitals. In 2004 during the epidemic phase, 2231 non-duplicated isolates were collected from 95 university hospitals and regional hospitals for nationwide survey. Of those, one isolate per hospital was arbitrarily selected, from which four isolates confirmed by us as having been misidentified using MALDI-TOF MS were omitted, making a total of 91 isolates from 91 hospitals. Those past isolates recovered from frozen bacterial stock libraries, and preserved in 1990 and 2004 by the Laboratory of Bacterial Drug Resistance, Gunma University Graduate School of Medicine, were provided for this investigation. In 2016 during the post-epidemic phase (decline phase), 178 non-duplicated isolates were collected from 68 university hospitals and regional hospitals which agreed to donates bacterial isolates to our nationwide investigation. The isolates were stored at À80 C and were subcultured on Müller-Hinton agar prior to DNA extraction. All MRSA isolates were confirmed as carrying the genes mecA and femA. For the purpose of evaluating the geographical deflection of MRSA clones, the isolates were divided into eastern and western Japan-derived strains depending on the location of hospitals; eastern Japan consisted of Hokkaido, Tohoku, Kanto and Koushinetsu regions, and western Japan consisted of Hokuriku, Tokai, Kinki, Chugoku, Shikoku, and Kyushu Okinawa regions.
Genotyping of MRSA isolates
Total DNA was extracted by Cica Geneus DNA Extraction Reagent (Kanto Chemical, Tokyo, Japan). Molecular typing of 353 MRSA isolates was performed by the polymerase chain reaction (PCR)-based open reading frame (ORF) Fig. 1 . Downward trend in observed yearly rates of methicillinresistant S. aureus isolation in Japan. The ratio of the number of patients with Staphylococcus aureus (S. aureus) or methicillin-resistant S. aureus (MRSA) to the total number of patient specimens submitted was plotted based on data from the Japan Nosocomial Infections Surveillance (JANIS) system. The ratio of the number of patients with methicillin-sensitive S. aureus (MSSA) was plotted by calculating the difference between S. aureus and MRSA ratios, because this was not provided by JANIS.
typing (POT) system, developed by Suzuki et al. [11] using the Cica Geneus Staph POT Kit (Kanto Chemical). Briefly, two multiplex-PCR reactions were performed using extracted DNA and specific primers that amplified 22 target genetic elements according to the manufacturer's instructions: 13 from integrated prophages (POT2-2 to -7, POT3-1 to -7), one from a genomic island (POT2-8), two from genomic islets (POT1-5, 6), one from a transposon (POT2-1) and five from the SCCmec elements (POT1-1 to -4, and -7) ( Table 1 ). The POT score for POT1, 2 and 3 was calculated based on the presence or absence of bands of PCR-amplified products in a binary manner. The POT1 score was calculated from the results of SCCmec elements and genomic islets, allowing estimation of clonal complexes (CCs) and identification of SCCmec types II and IV. POT2 and 3 scores were calculated mainly from the results of prophage-derived ORFs, allowing strain-level discrimination of MRSA.
The presence of the SCCmec cassette recombinase genes ccrA1 and ccrC, and mec gene complex class C, was further analysed, thereby allowing determination of additional SCCmec types I and V. In addition, the presence of five small genomic islets, SACOL2523, MW2292, SACOL1824, SAR2149 and SA0203, was analysed, allowing the estimation of CCs [12] . For the detection of those eight genes and the four toxin genes (tst, eta, etb and pvl [13] ) described below, a multiplex PCR was carried out using TaKaRa Ex Taq Hot Start Version (TakaRa Bio Inc., Shiga, Japan) and specific primers shown in Table 2 , with annealing temperature 60 C.
Multilocus sequence typing (MLST) was performed to confirm the sequence types (STs) of 14 isolates which belonged to diverged or divided groups on SplitsTree depiction despite sharing the same POT1 scores (Table S1 , available in the online version of this article). The STs were assigned through the Staphylococcus aureus MLST database (https://pubmlst.org/saureus/).
Detection of toxin genes
All MRSA isolates were screened for the presence of toxic shock syndrome toxin-1 (TSST-1) gene, tst, exfoliative toxin genes, eta and etb, staphylococcal enterotoxin genes, sea, seb, and sec and Panton-Valentine leukocidin gene, pvl. A multiplex PCR for the detection of staphylococcal enterotoxin genes was carried out as described previously [14] ( Table 2) .
Phylogenetic analyses
The genetic relationships of MRSA isolates were analysed based on 37 gene profiles by constructing NeighborNet graph using SplitsTree version 4.14.4 [15] . An input file was generated in nexus format, which contained the binary matrix indicating the presence (1) or absence (0) of genes.
RESULTS
Distribution of POT1 scores of MRSA isolates
Among 84 isolates collected in 1990, 21 (70 %) of 30 from eastern Japan showed a POT1 score of 93 ( Fig. 2 ). In contrast, of the 54 isolates from western Japan. isolates with a POT1 score of 93 were found in only 14 (26 %) in addition to 15 (28 %), 10 (19 %) and 6 isolates (11 %) with POT1 scores of 110, 100 and 106, respectively. Thus, isolates showing four different POT1 scores were prevalent in western Japan in 2009. Of the 91 isolates collected in 2004 corresponding to the MRSA epidemic phase, a POT1 score of 93 was predominant in both eastern (38 of 42 isolates, 91 %) and western Japan (35 of 49 isolates, 72 %). However, among the 178 isolates collected in 2016 corresponding to the declining phase of MRSA, the frequency of POT1 score 93 was reduced in both eastern (45 of 120 isolates, 38 %) and western Japan (27 of 58 isolates, 47 %). In contrast, a POT1 score of 106 was observed in eastern (58 of 120 isolates, 48 %) and western Japan (22 of 58 isolates, 38 %), though it was not found among the 2004 isolates.
Clonality analysis of MRSA isolates
Relationships among POT1 scores, SCCmec types and presumed CC (pCC) were investigated to gain insight into the epidemiology of MRSA clones. All 180 isolates with a POT1 score of 93 were SCCmec type II, estimated to belong to pCC5 including ST5, ST764 and a single-locus variant of ST764 (Tables 3 and S1 ). All 87 isolates with a POT1 score of 106 were SCCmec type IV, and belonged to either pCC1 Toxin gene profiles among MRSA isolates with POT1 scores of 106, 110 and 100
Of 87 isolates with a POT1 score of 106, the incidence of isolates carrying the sea gene, including sea and the sea-seb combination (40/87 isolates, 46.0 %) was predominant, followed by isolates carrying the tst-sec combination (18/87 isolates, 20.7 %) ( Table 3 ). The pCC of the isolates positive for the sea gene was mostly pCC1, and those positive for the tst-sec combination were pCC8. Carriage of the pvl gene was observed in four isolates (three from pus and one from blood), all of which were derived from eastern Japan in 2016. Among these, two pvl gene-positive isolates fell into a particular POT type with POT scores of 106-77-113 belonging to ST8 and a single-locus variant of ST8 (Table S1) , and the remaining two had POT scores of 106-79-113 and 106-77-125.
A high cumulative total of sea (13/17 isolates, 76 %) or pvl (9/17 isolates, 53 %) gene-positive isolates was recognized among isolates with a POT1 score of 110. In isolates with a POT1 score of 100, only the seb gene was detected (9/12 isolates).
The pvl gene was also detected in three isolates with a POT1 score of 64 (including one from blood) derived from eastern Japan in 2016, and in an isolate with a POT1 score of 79 from western Japan in 1990. Fig. 4(a) shows a phylogenetic network constructed for the 353 MRSA isolates based on 37 gene profiles, comprising 22 genes included in the POT system with an additional eight genes and seven toxin genes. There were two large genetic clusters with POT1 scores of 93 and 106, and two small genetic clusters, with POT1 scores of 100 and 110, with the formation of a reticular network which is indicative of recombination or horizontal gene transfer events. Longer branch lengths showing longer evolutionary distances were found between two large clusters. Time-dependent changes in gene profiles were observed among the isolates with a POT1 score of 93 (Fig. 4b) . Namely, the major part of the isolates with a POT1 score of 93 in 2016 formed a large cluster, while those from 1990 and 2004 mainly formed another large cluster, although genetic proximity was found among the isolates from 1990. Of note, the cluster of isolates mostly from 2016 was characterized by the carrying of seb genes, and another cluster of isolates, mostly from 1990 and 2004, was characterized by the carrying of tst or tst-sec genes (Fig. 4c) . Among isolates with a POT1 score of 106, pCC1 isolates, mostly including sea carriers, and pCC8 isolates, mostly including tst-sec carriers, were clustered separately except one isolate (Fig. 4d) . This isolate belonged to a single-locus variant of ST380 (CC8) (Table S1 ), although it was located within the pCC1 cluster. The four pvl-positive isolates showed close genetic proximity (Table 3) . SplitsTree analysis did not depict any geographical difference for MRSA isolates between eastern and western Japan.
Phylogenetic networks of 353 MRSA isolates
DISCUSSION
The POT system, aimed at detect ORFs derived from lysogenic prophages, has shown high discriminatory power comparable to pulsed-field gel electrophoresis. By combining such discriminatory ability with detectability of SCCmec types II and IV, which are commonly associated with HA-MRSA and CA-MRSA, respectively, and of genomic islets for CC estimation, the POT system has been evaluated as a simple and useful epidemiological tool in both outbreak analysis and in non-outbreak surveillance [11, 16, 17] . In this study, the identification of SCCmec types I and V, and the detection of five genomic islets and seven toxin genes, was additionally carried out to support our molecular approach for the epidemiological characterization of MRSA isolates.
The evidence-based reason for the decline in MRSA isolation in many countries around the world is still unknown, but it could possibly be explained by the success of infection control practices [18] [19] [20] . Another potential reason may lie in the progressive replacement of HA-MRSA clones by CA-MRSA clones in hospital settings [5, 6, 21] . Our analysis revealed that isolates with a POT1 score of 93 were identified as a major epidemic MRSA lineage in 1990 and 2004, although it was one of four predominant lineages in western Japan in 1990. Thus, the MRSA clone with a POT1 score of 93 may possibly have spread from eastern to western Japan during that period. Isolates with a POT1 score of 93 were identified as belonging to pCC5-SCCmec type II lineage, including ST5-SCCmec type II corresponding to the pandemic HA-MRSA New York/Japan clone [22] , and characterized by harbouring the tst gene at high frequency (84-94 %), among which tst only and the tst-sec combination were predominant. In 2016, a marked decrease in POT1 score 93 isolates, with an accompanying change in the epidemiology of toxin gene carriage, was noted, where the carriers of tst genes including the tst-sec combination had significantly declined, and those of the seb gene had significantly increased. The representative isolates of the seb gene carriers were identified as ST764 or a single-locus variant of ST764. The MRSA ST764 lineage, which is a singlelocus variant of ST5, was first reported in Japan as a hybrid variant of ST5 HA-MRSA with CA-MRSA by acquiring virulence genes including the seb gene but lacking the pvl, tst and sec genes [23] . These findings suggest a clonal shift from ST5 to the ST764/a single-locus variant of ST764, along with a shift in the toxin gene distribution from tst-sec to seb within the MRSA population with a POT 1 score of 93 during the change of phase from epidemic to postepidemic.
The clonal structure of the MRSA population was found to have moved in 2016, where isolates with a POT1 score of 106 became predominant rather than isolates with a POT1 score of 93, though this 106 clone was one of the four POT1 types mainly prevalent in western Japan in 1990 and was not detected in 2004. Isolates with a POT1 score of 106 belonged to pCC1-or pCC8-SCCmec type IV, which are associated with CA-MRSA. Interestingly, the pCC1 and pCC8 lineages were associated with sea and tst-sec carriage, respectively. Among four pvl-positive isolates belonging to lineage pCC8, two had a POT score of 106-77-113. According to the manufacturer's instructions, the score of 106-77-113 has typically been shown by many USA 300 strains, a successful CA-MRSA clone in North America. These two were identified as the ST8/a single-locus variant of ST8 by MLST, confirming that they were classified as USA300 MRSA (ST8-SCCmec type IV).
Our study showed that the POT1 score 110 isolates, belonging to SCCmec type IV and pCC30 including ST30, were characterized by frequent carriage of the sea and pvl genes. Those isolates were detected in 1990, accounting for 28 % in western Japan, but were not detected in 2004 and 2016. So, this pCC30-SCCmec type IV lineage is likely to have failed to become a successful MRSA clone in the hospital setting in Japan, and such findings are consistent with a previous report [24] . A similar trend was observed for isolates with a POT1 score of 100 belonging to SCCmec type I and pCC5, including ST5 and a single-locus variant of ST5, in that these were detected only in 1990. To the best of our knowledge, those isolates, characterized by harbouring seb genes at high frequency, have not been reported in Japan.
The epidemiology of MRSA evolved rapidly with the replacement of epidemic MRSA clones by their variants or new clonal types. Currently, CC5 and CC22 are regarded as the major epidemic clones reported in hospitals worldwide. In Japan, nationwide survey studies of recent MRSA isolates have rarely been conducted, where MRSA strains collected in 2010 and 2012 were subjected to analysis but limited to CA-MRSA [25] . Our nationwide population-based surveillance study targeted MRSA isolates collected from the pre-epidemic, epidemic and post-epidemic phases, thus enabling overall analysis of MRSA clone dynamics in Japan. The results revealed a clonal shift from New York/Japan clone (POT1 score 93) in the epidemic phase to CA-MRSA clones pCC1-SCCmec type IV and pCC8-SCCmec type IV (POT1 score 106) in the post-epidemic phase. Furthermore, the evolutionary shift from ST5 to ST764, a unique clone that has emerged only in Japan, may have occurred within the New York/Japan clone. Such clonal shift dynamics in MRSA populations, combined with the changes in infection prevention and control measures, may well contribute to the recent decline in the rate of MRSA isolation. Thus, continuous nationwide molecular epidemiologic survey on MRSA populations needs to be conducted for accurate understanding of the mechanisms underlying bacteriological dynamics. The POT system, which does not provide ST but is capable of estimating CC, could become a useful tool in conducting a large-scale epidemiological investigation.
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